PMID: 2495111Mar 4, 1989Paper

Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7

BMJ : British Medical Journal
R P CookeM J Painter

Abstract

To determine the incidence of secondary meningococcal infection in close family and household contacts of index patients and to review the efficacy of chemoprophylaxis the records of 3256 cases occurring from 1984 through 1987 were examined. Seventeen secondary cases (0.5%) of infection were identified among these groups. The median interval between index and secondary cases was seven weeks. Fourteen secondary cases occurred more than one week after the disease was diagnosed in the index case. Three secondary cases had not received chemoprophylaxis and in another case the infecting strain had acquired resistance to rifampicin. Prophylaxis for the close contacts of 10 out of 11 of the remaining index patients failed to fulfil all the criteria of an optimal regimen. Even after optimal chemoprophylaxis the medical practitioner and the family should be aware of the increased and prolonged risk of secondary meningococcal infection among close contacts of patients with the disease.

References

May 21, 1988·Lancet·P Baxter, B Priestley
Jun 1, 1988·The Journal of Antimicrobial Chemotherapy·R A Wall
Jan 1, 1986·The Journal of Pediatrics·E R CooperJ W Paisley
Apr 1, 1988·The Journal of Antimicrobial Chemotherapy·P N Gaunt, B E Lambert
Jun 22, 1974·Lancet·R S MunfordR A Feldman

❮ Previous
Next ❯

Citations

Jan 1, 1991·Transactions of the Royal Society of Tropical Medicine and Hygiene·D M Jones
Feb 1, 1991·Epidemiology and Infection·K A CartwrightP M Robinson
May 6, 1999·Current Opinion in Pulmonary Medicine·D A MooreJ S Friedland
Jan 11, 2000·Clinical Microbiology Reviews·M van DeurenJ W van der Meer
Oct 22, 2008·Infection and Immunity·Rachel M ExleyChristoph M Tang
Dec 1, 1996·Archives of Disease in Childhood·A J PollardM Levin
Mar 1, 1997·Archives of Disease in Childhood·R T Mayon-White, P T Heath
Dec 14, 1999·BMJ : British Medical Journal·A J Pollard, N Begg
Jun 5, 2004·BMJ : British Medical Journal·Bernadette PurcellJames M Stuart
Nov 24, 1999·Journal of Epidemiology and Community Health·K ArdernC M Regan
Apr 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·H P Lambert
Jul 3, 2008·International Journal of Health Geographics·Markus ReinhardtUlrich Vogel
Oct 23, 2004·Emerging Infectious Diseases·Christian J P A HoebeNico Nagelkerke
Jun 21, 2005·Emerging Infectious Diseases·Jean RainbowRuth Lynfield
Feb 8, 2007·Emerging Infectious Diseases·Johannes EliasUlrich Vogel
Aug 27, 2013·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Chris Salisbury
Sep 1, 1992·European Journal of Epidemiology·R Olivares, B Hubert
Feb 24, 2011·Expert Review of Anti-infective Therapy·Paola Stefanelli
Mar 15, 2015·Clinical Case Reports·Shin NihonyanagiHideaki Hanaki
Jul 1, 1990·The Journal of Infection·D M Jones, E M Sutcliffe
Sep 1, 1991·The Journal of Infection·R WallZ Vellani
May 25, 2012·Vaccine·David Pace, Andrew J Pollard
Mar 30, 2018·MMWR. Morbidity and Mortality Weekly Report·Emily Spence DavizonMeghan Barnes
Aug 18, 2004·Journal of Medical Microbiology·Siamak P Yazdankhah, Dominique A Caugant
Aug 12, 1998·Revista de saúde pública·D E BarrosoC A Solari
Mar 1, 1993·The Medical Journal of Australia·M S PatelS Jayathissa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.